REGN News

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN

REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

REGN CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

$REGN Fraud Notification: Regeneron Sued for Fraud Over Misrepresentations about its Clinical Trials – Investors Notified to Contact BFA Law

Pomerantz LLP Advises Shareholders of Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN

Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action – Contact Levi & Korsinsky

Recover Investment Losses: Class Action Initiated Against Regeneron Pharmaceuticals, Inc. (REGN)